OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use
Olivier Épaulard, Marlyse Buisson, Benjamin Némoz, et al.
Journal of Infection (2021) Vol. 84, Iss. 3, pp. 418-467
Open Access | Times Cited: 9

Showing 9 citing articles:

Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform
Christopher Chevillard, Axelle Amen, Solène Besson, et al.
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1913-1925
Open Access | Times Cited: 28

SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients
Quentin Perrier, Julien Lupo, Théophile Gerster, et al.
Vaccine (2022) Vol. 40, Iss. 44, pp. 6404-6411
Open Access | Times Cited: 28

Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants
Léa Dépéry, Isabelle Bally, Axelle Amen, et al.
Microbiology Spectrum (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
Charlotte Thibeault, Lara Bardtke, Kanika Vanshylla, et al.
JCI Insight (2023) Vol. 8, Iss. 8
Open Access | Times Cited: 4

Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology
Sundararaj Stanleyraj Jeremiah, Kei Miyakawa, Akihide Ryo
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 6

Humoral immune response to SARS-CoV-2 in five different groups of individuals at different environmental and professional risk of infection
Silvia Novello, Massimo Terzolo, Paola Berchialla, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 8

SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year
Erika Garner‐Spitzer, Angelika Wagner, Michael Kundi, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 4

A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination
Fabien Abdul, Pascale Ribaux, Aurélie Caillon, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2118-2118
Open Access | Times Cited: 4

Page 1

Scroll to top